Illumigyn

About

Funding history · 2 rounds · $38.0M total

Headcount over time

Q&A

What is Illumigyn's primary focus?

Illumigyn is an Israeli femtech startup developing a remote gynecological imaging platform for the early detection of cervical cancer and other diseases.

What is the total amount of funding Illumigyn has raised to date?

Illumigyn has raised a total of $38,000,000 in funding.

When did Illumigyn complete its Series B funding round and who were the lead investors?

In November 2021, Illumigyn completed a B Round, raising $33,000,000. The lead investors were Yozma Group Korea and Ubicom Holdings Japan.

What is the Gynescope System?

The Gynescope System is an FDA-cleared remote gynecological imaging platform developed by Illumigyn that uses high-resolution digital imaging and cloud-based technology to document the cervix, vagina, and external genitalia.

How many employees does Illumigyn currently have?

Illumigyn has 11-50 employees.

What is Illumigyn's strategy for expanding its gynecological imaging system in Africa?

In November 2021, Illumigyn partnered with Peramare Enterprises Ltd., supported by Afreximbank, to deploy its gynecological imaging system and cloud-based platform throughout Africa.

When was Illumigyn founded?

Illumigyn was founded in December 2012.

What is Illumigyn's primary sector?

Illumigyn's primary sector is Health Tech & Life Sciences.

Team · 3

Ran Poliakine

Founder · Co-founder & Senior Advisor to the Board

Lior Greenstein

Founder · Co-founder, President & CTO

Gad Ganon

Founder · Co-founder

Sectors & technology

Highlights

Tags